JP2007536906A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007536906A5 JP2007536906A5 JP2006541888A JP2006541888A JP2007536906A5 JP 2007536906 A5 JP2007536906 A5 JP 2007536906A5 JP 2006541888 A JP2006541888 A JP 2006541888A JP 2006541888 A JP2006541888 A JP 2006541888A JP 2007536906 A5 JP2007536906 A5 JP 2007536906A5
- Authority
- JP
- Japan
- Prior art keywords
- binding affinity
- gag binding
- less
- fold
- help
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000035118 modified proteins Human genes 0.000 description 2
- 108091005573 modified proteins Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0195203A AT412785B (de) | 2003-12-04 | 2003-12-04 | Gag-bindungsproteine |
| ATA1952/2003 | 2003-12-04 | ||
| PCT/EP2004/013670 WO2005054285A1 (en) | 2003-12-04 | 2004-12-02 | Gag binding proteins |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012040123A Division JP2012139226A (ja) | 2003-12-04 | 2012-02-27 | Ｇａｇ結合蛋白質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007536906A JP2007536906A (ja) | 2007-12-20 |
| JP2007536906A5 true JP2007536906A5 (https=) | 2012-04-12 |
| JP4980721B2 JP4980721B2 (ja) | 2012-07-18 |
Family
ID=33494536
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006541888A Expired - Fee Related JP4980721B2 (ja) | 2003-12-04 | 2004-12-02 | Ｇａｇ結合蛋白質 |
| JP2012040123A Pending JP2012139226A (ja) | 2003-12-04 | 2012-02-27 | Ｇａｇ結合蛋白質 |
| JP2012086483A Pending JP2012165747A (ja) | 2003-12-04 | 2012-04-05 | Ｇａｇ結合蛋白質 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012040123A Pending JP2012139226A (ja) | 2003-12-04 | 2012-02-27 | Ｇａｇ結合蛋白質 |
| JP2012086483A Pending JP2012165747A (ja) | 2003-12-04 | 2012-04-05 | Ｇａｇ結合蛋白質 |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US7585937B2 (https=) |
| EP (5) | EP2363411A1 (https=) |
| JP (3) | JP4980721B2 (https=) |
| KR (2) | KR101278459B1 (https=) |
| CN (1) | CN1890264B (https=) |
| AT (3) | AT412785B (https=) |
| AU (1) | AU2004295104B2 (https=) |
| BR (1) | BRPI0416544A (https=) |
| CA (1) | CA2546789A1 (https=) |
| CY (2) | CY1109480T1 (https=) |
| DE (1) | DE602004022595D1 (https=) |
| DK (2) | DK1689775T3 (https=) |
| ES (2) | ES2369139T3 (https=) |
| IL (1) | IL175565A0 (https=) |
| NZ (1) | NZ547612A (https=) |
| PL (2) | PL1689775T3 (https=) |
| PT (2) | PT1689775E (https=) |
| SG (1) | SG149000A1 (https=) |
| SI (2) | SI1689775T1 (https=) |
| WO (1) | WO2005054285A1 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT412785B (de) * | 2003-12-04 | 2005-07-25 | Kungl Andreas J Dr | Gag-bindungsproteine |
| ES2543341T3 (es) | 2005-09-13 | 2015-08-18 | National Research Council Of Canada | Métodos y composiciones para modular la actividad de células tumorales |
| CN100366637C (zh) * | 2005-11-17 | 2008-02-06 | 中国人民解放军第四军医大学 | 人白细胞介素8拮抗蛋白及其制备方法 |
| US9422356B2 (en) * | 2006-01-31 | 2016-08-23 | Republic Of Korea (Republic Of National Fisheries Research And Development Institute) | Artificial signal peptide for expressing an insoluble protein as a soluble active form |
| CA2822302A1 (en) | 2006-02-13 | 2007-08-23 | Alethia Biotherapeutics Inc. | Methods of impairing osteoclast differentiation |
| US8168181B2 (en) | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
| EP1894571A1 (en) * | 2006-08-29 | 2008-03-05 | Protaffin Biotechnologie AG | Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection |
| WO2008140500A2 (en) * | 2006-12-08 | 2008-11-20 | The University Of Miami | Hyaluronidase inhibitors as anti-cancer agents |
| AT504685B1 (de) * | 2006-12-20 | 2009-01-15 | Protaffin Biotechnologie Ag | Fusionsproteine |
| CA2686817A1 (en) * | 2007-05-07 | 2009-02-19 | Peptimmune, Inc. | Methods for the directed expansion of epitopes for use as antibody ligands |
| EP2042516A1 (en) * | 2007-09-27 | 2009-04-01 | Protaffin Biotechnologie AG | Glycosaminoglycan-antagonising MCP-1 mutants and methods of using same |
| ES2453592T3 (es) | 2007-08-02 | 2014-04-08 | Novimmune Sa | Anticuerpos anti-RANTES y métodos de uso de los mismos |
| EP2053060A1 (en) * | 2007-10-24 | 2009-04-29 | Protaffin Biotechnologie AG | SDF-1-based glyocosaminoglycan antagonists and methods of using same |
| US8314212B2 (en) * | 2008-02-08 | 2012-11-20 | Lindsey Miles | Plasminogen receptor PLG-RKT and antibodies thereof |
| WO2010086426A1 (en) | 2009-01-30 | 2010-08-05 | Protaffin Biotechnologie Ag | Glycosaminoglycan-antagonising mcp-i mutants and methods of using same |
| EP2475380A1 (en) | 2009-09-11 | 2012-07-18 | Protaffin Biotechnologie AG | Composition for treatment of cxcl8-mediated lung inflammation |
| EA034462B1 (ru) | 2009-11-24 | 2020-02-11 | Алетиа Байотерапьютикс Инк. | Антикластериновые антитела и антигенсвязывающие фрагменты и их использование для уменьшения объема новообразований |
| GB201012603D0 (en) * | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Protein purification |
| WO2012123585A1 (en) | 2011-03-16 | 2012-09-20 | Protaffin Biotechnologie Ag | Fgfr1-based antagonists with improved glycosaminoglycan affinity and methods of using same |
| WO2013007704A2 (en) | 2011-07-08 | 2013-01-17 | Protaffin Biotechnologie Ag | Novel sdf-1-based glycosaminoglycan antagonist and methods of using same |
| US9822170B2 (en) | 2012-02-22 | 2017-11-21 | Alethia Biotherapeutics Inc. | Co-use of a clusterin inhibitor with an EGFR inhibitor to treat cancer |
| HK1210192A1 (en) | 2012-07-19 | 2016-04-15 | Alethia Biotherapeutics Inc. | Anti-siglec-15 antibodies |
| WO2014079957A1 (de) * | 2012-11-23 | 2014-05-30 | Bayer Cropscience Ag | Selektive inhibition der ethylensignaltransduktion |
| WO2014109519A1 (ko) * | 2013-01-10 | 2014-07-17 | 강원대학교산학협력단 | 작은안구증-연관 전사인자 유래의 펩타이드 및 이를 포함하는 조성물 |
| EP3096776B1 (en) | 2014-01-22 | 2020-12-02 | Antagonis Biotherapeutics GmbH | Novel glycosaminoglycan-antagonising fusion proteins and methods of using same |
| US20220281934A1 (en) | 2019-08-29 | 2022-09-08 | Antagonis Biotherapeutics Gmbh | T-cell mobilizing cxcl10 mutant with increased glycosaminoglycan binding affinity |
| CN110791523B (zh) * | 2019-12-13 | 2022-05-10 | 南京农业大学 | 一种棉花抗旱相关基因GhRCHY1及其应用 |
| KR20250040765A (ko) * | 2023-09-15 | 2025-03-25 | (주)케어젠 | 펩타이드를 유효성분으로 하는 발모 촉진 또는 탈모증의 억제, 예방 또는 개선용 조성물 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4960691A (en) * | 1986-09-29 | 1990-10-02 | Abbott Laboratories | Chromatographic test strip for determining ligands or receptors |
| US5234911A (en) * | 1990-07-09 | 1993-08-10 | Gist-Brocades, N.V. | Substance with interleukin-8 inhibiting activity and process for its preparation |
| AU8947791A (en) * | 1990-11-01 | 1992-05-26 | Scripps Research Institute, The | Glycosaminoglycan-targeted fusion proteins, their design, construction and compositions |
| DK0607777T3 (da) * | 1993-01-08 | 1999-08-16 | Hoechst Ag | Anvendelse af leflunomid til inhibering af interleukin 8 |
| JP2694321B2 (ja) * | 1993-03-10 | 1997-12-24 | 大塚製薬株式会社 | インターロイキン−１阻害剤 |
| US5527546A (en) * | 1994-08-10 | 1996-06-18 | Bayer Corporation | Human interleukin 6 inhibitor |
| US5866402A (en) | 1995-05-05 | 1999-02-02 | Chiron Corporation | Chimeric MCP and DAF proteins with cell surface localizing domain |
| JPH1045602A (ja) * | 1996-07-31 | 1998-02-17 | Motoyasu Murakami | ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−８産生阻害剤 |
| US6852696B2 (en) * | 1999-03-26 | 2005-02-08 | The University Of Texas System | Inhibitors of glycosaminoglycans |
| EP2272947B1 (en) | 2000-09-05 | 2016-08-10 | Biosight Ltd | Peptide conjugated anti-cancer prodrugs |
| UA77950C2 (en) * | 2000-10-04 | 2007-02-15 | Applied Research Systems | Use of mutants of cc chemokines for treatment of multiple sclerosis |
| GB0110430D0 (en) * | 2001-04-27 | 2001-06-20 | Medical Res Council | Protein variants and uses thereof |
| JP2003063980A (ja) * | 2001-08-28 | 2003-03-05 | Noevir Co Ltd | Ｒａｎｔｅｓ産生阻害剤 |
| US6982170B1 (en) * | 2001-12-17 | 2006-01-03 | Maine Medical Center Research Institute | Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1 |
| JP2003306438A (ja) * | 2002-02-18 | 2003-10-28 | Shiseido Co Ltd | ケモカイン発現阻害剤 |
| JP2003267887A (ja) * | 2002-03-15 | 2003-09-25 | Shiseido Co Ltd | ケモカイン発現抑制皮膚外用剤 |
| IL164376A0 (en) * | 2002-04-03 | 2005-12-18 | Applied Research Systems | Ox4or binding agents, their preparation and pharmaceutical compositions containing them |
| AU2003240765A1 (en) * | 2002-04-10 | 2003-10-20 | Applied Research Systems Ars Holding N.V. | Novel antagonists of mcp proteins |
| AT412785B (de) * | 2003-12-04 | 2005-07-25 | Kungl Andreas J Dr | Gag-bindungsproteine |
-
2003
- 2003-12-04 AT AT0195203A patent/AT412785B/de not_active IP Right Cessation
-
2004
- 2004-12-02 SI SI200431747T patent/SI1689775T1/sl unknown
- 2004-12-02 DE DE602004022595T patent/DE602004022595D1/de not_active Expired - Lifetime
- 2004-12-02 EP EP10174625A patent/EP2363411A1/en not_active Withdrawn
- 2004-12-02 NZ NZ547612A patent/NZ547612A/en not_active IP Right Cessation
- 2004-12-02 KR KR1020127011106A patent/KR101278459B1/ko not_active Expired - Fee Related
- 2004-12-02 KR KR1020067013411A patent/KR101188785B1/ko not_active Expired - Fee Related
- 2004-12-02 PL PL04801190T patent/PL1689775T3/pl unknown
- 2004-12-02 EP EP10180974A patent/EP2270038A3/en not_active Withdrawn
- 2004-12-02 SI SI200431257T patent/SI1752470T1/sl unknown
- 2004-12-02 DK DK04801190.2T patent/DK1689775T3/da active
- 2004-12-02 PL PL06117339T patent/PL1752470T3/pl unknown
- 2004-12-02 EP EP04801190A patent/EP1689775B1/en not_active Expired - Lifetime
- 2004-12-02 EP EP10180909A patent/EP2311866A1/en not_active Withdrawn
- 2004-12-02 DK DK06117339T patent/DK1752470T3/da active
- 2004-12-02 JP JP2006541888A patent/JP4980721B2/ja not_active Expired - Fee Related
- 2004-12-02 PT PT04801190T patent/PT1689775E/pt unknown
- 2004-12-02 CN CN200480036160.6A patent/CN1890264B/zh not_active Expired - Fee Related
- 2004-12-02 AU AU2004295104A patent/AU2004295104B2/en not_active Ceased
- 2004-12-02 AT AT04801190T patent/ATE515269T1/de active
- 2004-12-02 WO PCT/EP2004/013670 patent/WO2005054285A1/en not_active Ceased
- 2004-12-02 CA CA002546789A patent/CA2546789A1/en not_active Abandoned
- 2004-12-02 PT PT06117339T patent/PT1752470E/pt unknown
- 2004-12-02 ES ES04801190T patent/ES2369139T3/es not_active Expired - Lifetime
- 2004-12-02 AT AT06117339T patent/ATE439376T1/de active
- 2004-12-02 EP EP06117339A patent/EP1752470B1/en not_active Expired - Lifetime
- 2004-12-02 BR BRPI0416544-6A patent/BRPI0416544A/pt not_active IP Right Cessation
- 2004-12-02 ES ES06117339T patent/ES2330362T3/es not_active Expired - Lifetime
- 2004-12-02 SG SG200809009-4A patent/SG149000A1/en unknown
-
2006
- 2006-05-11 IL IL175565A patent/IL175565A0/en unknown
- 2006-06-05 US US11/422,169 patent/US7585937B2/en not_active Expired - Fee Related
-
2008
- 2008-06-02 US US12/131,311 patent/US7807413B2/en not_active Expired - Fee Related
-
2009
- 2009-05-07 US US12/437,121 patent/US20110144305A1/en not_active Abandoned
- 2009-10-08 CY CY20091101039T patent/CY1109480T1/el unknown
-
2010
- 2010-08-18 US US12/858,456 patent/US20100331237A1/en not_active Abandoned
-
2011
- 2011-09-16 CY CY20111100904T patent/CY1112330T1/el unknown
-
2012
- 2012-02-27 JP JP2012040123A patent/JP2012139226A/ja active Pending
- 2012-04-05 JP JP2012086483A patent/JP2012165747A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007536906A5 (https=) | ||
| Thompson et al. | The ribosomal protein Asc1/RACK1 is required for efficient translation of short mRNAs | |
| JP2010529860A5 (https=) | ||
| JP2006502416A5 (https=) | ||
| JP2007508034A5 (https=) | ||
| French et al. | Core sequence of PAPf39 amyloid fibrils and mechanism of pH-dependent fibril formation: the role of monomer conformation | |
| Veglia et al. | The structure of the metal-binding motif GMTCAAC is similar in an 18-residue linear peptide and the mercury binding protein MerP | |
| Natalello et al. | Compact conformations of α‐synuclein induced by alcohols and copper | |
| Lind et al. | Post translational modifications in adenovirus type 2 | |
| Newcomer et al. | The phage L capsid decoration protein has a novel OB-fold and an unusual capsid binding strategy | |
| Ospinal-Jimenez et al. | Structural analysis of protein denaturation with alkyl perfluorinated sulfonates | |
| JP2006527990A5 (https=) | ||
| CN104650185A (zh) | 一条与猪瘟e0蛋白相结合的多肽序列及其应用 | |
| WO2024138472A1 (zh) | 孔蛋白单体、孔蛋白及其突变体和其应用 | |
| Lim et al. | The K15 protein of Kaposi's sarcoma-associated herpesvirus recruits the endocytic regulator intersectin 2 through a selective SH3 domain interaction | |
| WO2007052102A3 (en) | Modified green fluorescent proteins and methods for using same | |
| WO2003060098A3 (en) | Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to hiv-1 rna | |
| DK1297110T3 (da) | Attenueret bovin respiratorisk syncytialvirus | |
| CN105504015A (zh) | 一种mhc-i类限制性抗肿瘤ctl表位肽 | |
| Kiyokawa et al. | Engineering of the hydrophobic core of an α‐helical coiled coil | |
| Zughul et al. | Thermodynamics of propylparaben/β-cyclodextrin inclusion complexes | |
| JP2016505514A5 (https=) | ||
| Lithanatudom et al. | Analysis of protein profiling studies of β‐thalassemia/Hb E disease | |
| Gundapaneni et al. | High flexibility of the actomyosin crossbridge resides in skeletal muscle myosin subfragment-2 as demonstrated by a new single molecule assay | |
| JP2005516604A5 (https=) |